Teva Pharmaceutical falls 6% on eve of Q3 earnings show | Seeking Alpha
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
Earnings Preview: What To Expect From Teva Pharmaceutical On Thursday
Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week
TEVA Gears Up to Report Q4 Earnings: What's in the Cards?
TEVA Stock Up on Q4 Earnings Beat, Sales Miss Estimates
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Stock Climbs as Earnings Hint at Turnaround | Barron's
Teva's (TEVA) Q3 Earnings and Revenues Miss, Stock Down | Nasdaq